menu close
www.zetagen.com

ZetaGen Therapeutics Stock

Company Profile:

Zetagen Therapeutics is a private, clinical-stage biopharmaceutical company dedicated to developing innovative therapies for metastatic and primary cancers affecting bones and other organs. Utilizing their proprietary "Zeta" platform, the company focuses on local administration of treatments designed to suspend cancer progression, alleviate pain, and promote bone regeneration.

Sign up for SecondMarket® to view the market and buy or sell ZetaGen Therapeutics Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

ZetaGen Therapeutics Management Team

  • Board Member

    Donald Brown

  • Board Member

    Richard Warburg

  • CEO, Board Member

    Joe C. Loy

  • Chief Scientific Officer

    Bryan Margulies

  • Chief Medical Officer, Board Member

    Nikhil Thakur

  • Board Member

    Ashok Kaveeshwar

  • CFO, COO

    Jess Pletka

Learn More About ZetaGen Therapeutics Stock

Buy ZetaGen Therapeutics Stock
01

ZetaGen Therapeutics stock does not trade on public stock exchanges. ZetaGen Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ZetaGen Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell ZetaGen Therapeutics Stock
02

ZetaGen Therapeutics Stock does not trade on public stock exchanges. In order to sell ZetaGen Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

ZetaGen Therapeutics Stock Price
03

ZetaGen Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view ZetaGen Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

ZetaGen Therapeutics Stock Ticker Symbol
04

There is no ticker symbol for ZetaGen Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell ZetaGen Therapeutics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ZetaGen Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in ZetaGen Therapeutics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ZetaGen Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

ZetaGen Therapeutics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

ZetaGen Therapeutics IPO
08

ZetaGen Therapeutics is a private company and has not had an IPO. There is currently no ZetaGen Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to ZetaGen Therapeutics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell ZetaGen Therapeutics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Tessera Therapeutics-Logo

Tessera Therapeutics

Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Source: Nasdaq Private Market Tape D®